CIP
LUNG icon

Champlain Investment Partners’s Pulmonx LUNG Stock Holding History

Champlain Investment Partners’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,701,250
Closed -$22.8M – 132
2022
Q4 		$22.8M Sell
2,701,250
-101,210
-4% -$963K 0.15% 127
2022
Q3 		$46.7M Buy
2,802,460
+672,700
+32% +$12.4M 0.32% 105
2022
Q2 		$31.4M Sell
2,129,760
-59,755
-3% -$1.23M 0.2% 120
2022
Q1 		$54.3M Buy
2,189,515
+102,370
+5% +$2.64M 0.28% 110
2021
Q4 		$66.9M Buy
2,087,145
+285,580
+16% +$10.4M 0.3% 111
2021
Q3 		$64.8M Buy
1,801,565
+736,550
+69% +$29M 0.31% 116
2021
Q2 		$47M Buy
1,065,015
+592,270
+125% +$25.8M 0.22% 120
2021
Q1 		$21.6M Buy
+472,745
New +$27.1M 0.11% 126

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Champlain Investment Partners's LUNG Position: Q1 2023 in Review

Champlain Investment Partners sold out of Pulmonx (LUNG) in Q1 2023, closing a stake of 2,701,250 shares — an estimated $22.8M sold.

Champlain Investment Partners first reported a position in LUNG in Q1 2021 and held it in 8 quarters. The position peaked at $66.9M in Q4 2021. 102 funds tracked by Wall St. Rank hold LUNG as of Q1 2023.

  • Champlain Investment Partners reported no remaining Pulmonx position as of Q1 2023 after selling out during the quarter.
  • Champlain Investment Partners sold 2,701,250 Pulmonx shares in Q1 2023, an estimated $22.8M.
  • Champlain Investment Partners first reported a position in Pulmonx in Q1 2021 and held it in 8 quarters.
  • Champlain Investment Partners's Pulmonx position peaked at $66.9M in Q4 2021.
  • 102 funds tracked by Wall St. Rank held Pulmonx as of Q1 2023.

Based on Champlain Investment Partners's 13F filing for Q1 2023, filed 12 May 2023.